Phenotyping Post TB Obstructive airways disease (TOPD) in India

R. Dhar (Kolkata , India), G. Nair ( Navi Mumbai, India), . Jana ( Salem, India), . Shah (Vadodara, India), A. Dalal (Mumbai, India), . Rajagopala (Coimbatore, India), M. Sarkar (Shimla, India), J. Unnithan (Coimbatore, India), . Shah (Vadodara, India), . Krishnamurthy (Coimbatore, India), P. Shahi (Kolkata , India), S. Patel ( Navi Mumbai, India), V. Chaudhary (Vadodara, India), . Patil (Mumbai, India), P. Karumalai (Coimbatore, India), P. Shah (Vadodara, India), S. Balasubramaniam (Coimbatore, India), s. J (Pune , India), . Kale (Pune , India), . Madas (Pune , India), S. Limaye (Pune , India), . Pawar (Pune , India), S. Salvi (Pune , India)

Source: International Congress 2019 – Treatment of airway diseases in primary care
Session: Treatment of airway diseases in primary care
Session type: Thematic Poster
Number: 734
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Dhar (Kolkata , India), G. Nair ( Navi Mumbai, India), . Jana ( Salem, India), . Shah (Vadodara, India), A. Dalal (Mumbai, India), . Rajagopala (Coimbatore, India), M. Sarkar (Shimla, India), J. Unnithan (Coimbatore, India), . Shah (Vadodara, India), . Krishnamurthy (Coimbatore, India), P. Shahi (Kolkata , India), S. Patel ( Navi Mumbai, India), V. Chaudhary (Vadodara, India), . Patil (Mumbai, India), P. Karumalai (Coimbatore, India), P. Shah (Vadodara, India), S. Balasubramaniam (Coimbatore, India), s. J (Pune , India), . Kale (Pune , India), . Madas (Pune , India), S. Limaye (Pune , India), . Pawar (Pune , India), S. Salvi (Pune , India). Phenotyping Post TB Obstructive airways disease (TOPD) in India. 734

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiac Involvement In Chronic Obstructive Pulmonary Disease (COPD) Secondary To Post TB Bronchiectasis V/S Non Post Tb Bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Unemployment in chronic airflow obstruction (CAO) around the world: Results from the Burden of Obstructive Lung Disease (BOLD) study
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Rate of FVC decline in a primary care UK Chronic Obstructive Pulmonary Disease (COPD) population
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019



Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013



Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Prevalence of Pneumocystis jirovecii colonization in patients with Chronic Obstructive Pulmonary Disease (COPD) in Bogotá, Colombia.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017




Copy Number Variation (CNV) in Chronic Obstructive Pulmonary Disease (COPD) with and without ongoing smoking
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020


COPD prevalence in Portugal. The Burden of Obstructive Lung Disease study (BOLD)
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018


The ALONNISOS STUDY: Cross-sectional study of the prevalence of Obstructive Sleep Apnea Syndrome (OSAS) and Chronic Obstructive Pulmonary Disease (COPD) in the general population of Alonissos.
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020


Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark
Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes
Year: 2021


Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Sri Lanka:outcome of the BOLD study
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Chronic Obstructive Pulmonary Disease (COPD) as co-morbidity in patients with Obstructive Sleep Apnea Syndrome (OSAS): Results of a retrospective study in the French overseas department of Reunion island.
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021


Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019